Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 23456765)

1.

Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant.

Xu M, Xing Y, Zhou L, Yang X, Yao W, Xiao W, Ge C, Ma Y, Yang J, Wu J, Cao R, Li T, Liu J.

Tumour Biol. 2013 Jun;34(3):1399-408. doi: 10.1007/s13277-012-0616-8. Epub 2013 Mar 1.

PMID:
23456765
2.

Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.

Chen XY, Zhang W, Zhang W, Wu S, Bi F, Su YJ, Tan XY, Liu JN, Zhang J.

Clin Cancer Res. 2006 Oct 1;12(19):5834-40.

3.

Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine.

Xu M, Zhou L, Zhang P, Lu Y, Ge C, Yao W, Xing Y, Xiao W, Dong Y, Wu J, Cao R, Li T.

Tumour Biol. 2013 Oct;34(5):3173-82. doi: 10.1007/s13277-013-0887-8. Epub 2013 Jun 15.

PMID:
23771850
4.

Enhanced inhibition of murine prostatic carcinoma growth by immunization with or administration of viable human umbilical vein endothelial cells and CRM197.

Huiyong Z, Yong L, Didier M, Yu Z, Jing F, Rongyue C, Jingjing L.

Braz J Med Biol Res. 2011 Feb;44(2):140-8. Epub 2010 Dec 17.

6.

[The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].

Luo F, Mao YQ, Kan B, He QM, Jiang Y, Peng F, Yang L, Tian L.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Nov;35(6):757-60. Chinese.

PMID:
15573746
7.

[Anti-tumor immune response against mouse melanoma to xenogeneic vaccination].

Luo F, Wei Y, Kan B.

Zhonghua Zhong Liu Za Zhi. 2001 Mar;23(2):118-21. Chinese.

PMID:
11783014
8.
9.

Local injection of OK432 can augment the TH1-type T-cell response in tumor-draining lymph node cells and increase their immunotherapeutical potential.

Okamoto T, Harada M, Tamada K, Yoshida H, Ito O, Kong YY, Takenoyama M, Hirashima C, Matsuzaki G, Nomoto K.

Int J Cancer. 1997 Mar 4;70(5):598-605.

PMID:
9052762
11.

The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cells.

Kurosawa S, Harada M, Shinomiya Y, Terao H, Nomoto K.

Cancer Immunol Immunother. 1996 Sep;43(1):31-8.

PMID:
8917633
12.

Antitumor vaccination effect of dendritic cells can be augmented by locally utilizing Th1-type cytokines from OK432-reactive CD4+ T cells.

Tamada K, Harada M, Abe K, Li T, Tada H, Onoe Y, Nomoto K.

Cancer Immunol Immunother. 1998 May;46(3):128-36.

PMID:
9625536
13.

Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma.

Bellone M, Cantarella D, Castiglioni P, Crosti MC, Ronchetti A, Moro M, Garancini MP, Casorati G, Dellabona P.

J Immunol. 2000 Sep 1;165(5):2651-6.

14.

Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.

Mattarollo SR, Steegh K, Li M, Duret H, Foong Ngiow S, Smyth MJ.

Immunol Cell Biol. 2013 Jan;91(1):105-14. doi: 10.1038/icb.2012.58. Epub 2012 Oct 23.

PMID:
23090488
16.

[Study on the specific immunity of dendritic cell vaccine loading human umbilical vein endothelial cell antigen against U14 cervical cancer].

Zhao J, Zhai JM, Lu J, Yang HY, Huang YT, Li S, Dong ZM, Zhang X.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Mar;25(3):196-200. Chinese.

PMID:
19257979
17.

Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.

Heimberger AB, Crotty LE, Archer GE, Hess KR, Wikstrand CJ, Friedman AH, Friedman HS, Bigner DD, Sampson JH.

Clin Cancer Res. 2003 Sep 15;9(11):4247-54.

18.

Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line.

Yoshiura K, Nishishita T, Nakaoka T, Yamashita N, Yamashita N.

J Exp Clin Cancer Res. 2009 Jan 31;28:13. doi: 10.1186/1756-9966-28-13.

19.

Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity.

Okaji Y, Tsuno NH, Kitayama J, Saito S, Takahashi T, Kawai K, Yazawa K, Asakage M, Hori N, Watanabe T, Shibata Y, Takahashi K, Nagawa H.

Cancer Sci. 2004 Jan;95(1):85-90.

PMID:
14720332
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk